ClinLabNavigator Logo
ANA
Available Documents
New Documents
ABO Blood Group System
Acute Hemolytic Transfusion Reaction
Allergic Reactions
Anaphylactic Reactions
Antibody Adsorption Procedures
Antibody Identification
Apheresis
Autologous Blood Donation
Blood Infusion
Blood Salvage
CMV Negative Blood Components
Compatibility Testing
Cord Blood Direct Antiglobulin Testing
Cryoprecipitate
Delayed Hemolytic Transfusion Reaction
Direct Antiglobulin Test
Directed Blood Donations
Drug Induced Thrombocytopenia
Febrile Nonhemolytic Reactions
Fetal Maternal Hemorrhage
Hemophilia A
Hemophilia B
Heparin Induced Thrombocyopenia
Previous Documents
ABO Blood Group System
ABO Mismatched Allogeneic Transplants
Albumin
Autoimmune Hemolytic Guidelines
Blood Administration
Blood Component Transfusion Guidelines
Blood Donation
CMV Negative Blood Components
Compatibility Testing
Cryoprecipitate
Factor IX Complex
Factor VIIa
Factor VIII Concentrate
Factor VIII Inhibitors
Fresh Frozen Plasma
Granulocyte Transfusion
Hemolysis Following Allogeneic BMT
Informed Consent
Irradiated Blood Components
Leukocyte Reduced Red Cells & Platelets
Massive Transfusion
Neonatal Alloimmune Thrombocytopenia
Nitric Oxide Banked Blood
Other Blood Group Systems
Pediatric & Neonatal Transfusion Practices
Platelet Transfusion
Prenatal & Perinatal Immunohematologic Testing
RBC Transfusion Trigger
Red Blood Cell Transfusion
Rh Blood Group System
RhIG for HDN Prevention
RhIG for Treatment of ITP
Saline Washed Red Blood Cells
Sickle Cell Disease Transfusion
Therapeutic Apheresis
Thrombotic Thrombocytopenic Purpura
Transfusion Reactions
Transfusion Related Acute Lung Injury
Trypanosoma Cruzi Donor Screening
Umbilical Cord Blood Stem Cells
von Willebrands Disease
Warm Autoimmune Hemolytic Anemia
Transfusion

Allergic Reactions

Print This Page
E-mail This Page

Simple allergic reactions are the second most common type of transfusion complication. Allergic reactions occur most commonly after the transfusion of components containing large volumes of plasma such as fresh frozen plasma, plasma frozen within 24 hours, single donor platelets or pooled random donor platelet concentrates. Transfusion of red blood cells is less commonly associated with allergic reactions because they contain so little plasma.



Etiology: Allergic reactions are attributed to soluble substances in donor plasma (e.g. food allergens, drugs or ethylene oxide) which react with IgE antibody bound to basophils or mast cells in the recipient's blood. This interaction results in the release of C3a, C5a, histamine, prostaglandin D2, leukotrienes C and D4 and a variety of other cytokines. These substances produce an immediate type hypersensitivity reaction by increasing vascular permeability, promoting bronchial smooth muscle contractions, and stimulating mucus secretion by nasal and bronchial glands. Histamine release causes hives, itching, and rarely, laryngeal edema.

Symptoms: Hives (urticaria) or other rash (erythema), itching (pruritis), and wheezing are most common. Allergic reactions can occur during or up to 3 hours post-transfusion. The shorter the time interval is between the start of the transfusion and the onset of the allergic reaction, the more severe the reaction. In more severe reactions, anxiety, dyspnea, palpitations, fever and chills may accompany urticaria.

Consequences: Allergic reactions are not usually dangerous, but they do cause discomfort and anxiety. Urticaria is not a manifestation of a hemolytic reaction, so it is not usually necessary to discontinue the transfusion.



Lab Data: No laboratory testing is necessary.

Treatment:
  • Slow the rate of transfusion for 15 to 30 minutes.
  • Give an antihistamine to ease discomfort.
  • Monitor carefully because urticaria could be the first sign of a more serious allergic reaction.
  • If the only symptom is skin rash or hives and the symptoms resolve within 30 minutes of treatment, the transfusion can be resumed.
Prevention: Patients who have had 2 or more allergic reactions benefit from oral or parenteral prophylactic treatment with diphenhydramine one hour prior to transfusion and at the start of transfusion. If reactions continue, cellular products can be washed to remove residual plasma containing the soluble allergens. Corticosteroids may be necessary in severe, repetitive cases.